Clinical Trial
Study Details
Enrollment
44
Phase
N/A
Status
COMPLETED
Study ID #
NCT03876821
Study Type
Observational
Summary
The study consists in collecting umbilical cord blood cells from newborns at risk of sickle cell disease, to perform laboratory experiments aiming to characterize the cells with HbS/HbS mutation, to develop methods to prepare, to gene-modify and to preserve these cells.
Study Overview
Conditions
Description
Pregnant individuals carrying at least one HbS allele will be included in the study to collect the umbilical cord blood of the child at birth. Collected cells will be used anonymously for genetic and bioexperimental laboratory research, aiming to develop autologous gene therapy for sickle cell disease.
Contacts and Locations
Locations
Facility
CHSF
91106 Corbeil-Essonnes
France
GeoPoint
48.60603, 2.48757